Company Filing History:
17 out of 3,687 
1 out of 1,929 
1 out of 832,843 Years Active: 1992-2014
Title: The Innovative Contributions of Robert J Cotter
Introduction
Robert J Cotter is a prominent inventor based in Baltimore, MD, known for his significant contributions to the field of biomedical research. With a total of 18 patents to his name, Cotter has made remarkable advancements in the diagnosis and treatment of various diseases, particularly in the realm of multiple sclerosis.
Latest Patents
Among his latest patents is the development of an albumin-bound protein/peptide complex as a biomarker for disease. This innovation includes methods and kits for diagnosis and prognosis using biomarkers comprising the albumin-bound protein/peptide complex (ABPPC). Additionally, Cotter has patented methods for diagnosing and optimizing treatment for multiple sclerosis. His work describes biological markers for multiple sclerosis and their application in diagnosis and prognosis. Furthermore, he has outlined methods for treating multiple sclerosis by administering an inhibitor of cathepsin B activity or a neuroprotective composition that includes a modified terpenoid compound. His patents also cover isolated polypeptide biomarkers, polynucleotides encoding these biomarkers, and specific antibodies that bind to them. Kits that incorporate these isolated polypeptide biomarkers, polynucleotides, or specific antibodies are also part of his innovative contributions.
Career Highlights
Throughout his career, Robert J Cotter has worked with esteemed institutions such as The Johns Hopkins University and the University System of Maryland. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Cotter has collaborated with notable colleagues, including Vladimir M Doroshenko and Benjamin D Gardner. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Robert J Cotter's contributions to biomedical research and his extensive patent portfolio underscore his role as a leading inventor in the field. His work continues to impact the diagnosis and treatment of diseases, particularly multiple sclerosis, showcasing the importance of innovation in healthcare.